We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current MRVI market cap is 1.42B. The company's latest EPS is USD -0.4714 and P/E is -11.90.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 64.55M | 77.43M | 64.18M | 74.6M | 65.38M |
| Operating Income | -19.52M | -7.22M | -18.86M | -9.51M | -169.11M |
| Net Income | -6.46M | -105.96M | -12.08M | -7.59M | -99.04M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 303.1M | 810.49M | 890.8M | 292.23M |
| Operating Income | 119.9M | 554.65M | 574.22M | -31.65M |
| Net Income | 88.97M | 182.04M | 220.21M | -119.03M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 2.27B | 1.49B | 1.44B | 1.45B | 1.28B |
| Total Liabilities | 1.38B | 697.57M | 667.25M | 671.19M | 665.09M |
| Total Equity | 892.28M | 789.88M | 777.39M | 776.41M | 613.13M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.27B | 1.92B | 2.28B | 1.49B |
| Total Liabilities | 1.12B | 1.37B | 1.38B | 697.57M |
| Total Equity | 154.75M | 545.36M | 905.24M | 789.88M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | 118.43M | 126.22M | -8.47M | 8.97M | 22.1M |
| Investing | -109.41M | -122.31M | -4.24M | -10.43M | -19.39M |
| Financing | -61.56M | -61.09M | -560k | -332k | 477k |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 152.19M | 368.57M | 535.98M | 126.22M |
| Investing | 6.07M | 105.66M | -267.61M | -122.31M |
| Financing | 53.21M | -159.05M | -187.5M | -61.09M |
| Market Cap | 1.42B |
| Price to Earnings Ratio | -11.90 |
| Price to Sales Ratio | 4.85 |
| Price to Cash Ratio | 2.46 |
| Price to Book Ratio | 1.79 |
| Dividend Yield | - |
| Shares Outstanding | 252.53M |
| Average Volume (1 week) | 2.17M |
| Average Volume (1 Month) | 1.98M |
| 52 Week Change | -11.91% |
| 52 Week High | 11.555 |
| 52 Week Low | 4.275 |
| Spread (Intraday) | 5.17 (58.62%) |
| Company Name | Maravai LifeSciences Holdings Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
